The company Inner Cosmos released the first images of its brain implant for treating depression.
A neurotech startup unveiled a device that tackles depression and is already within the skull of the first patient, while Elon Musk’s Neuralink anticipates starting human trials in six months.
The digital pill from Inner Cosmos has two components: an electrode that rests beneath the scalp’s skin and a prescription pod that fastens to the wearer’s hair to supply electricity.
Once daily for 15 minutes, the implant delivers minute electrical pulses to the depression-prone left dorsolateral prefrontal cortex. And the external gadget does not need to be on the head while treatment is not being provided.
Human Trial Set To Start Next Month
One year will be used to test the Inner Cosmos invention on St. Louis, Missouri, trial patient, and the company will begin a new human experiment the following month.
Implants to address all alignments of the brain are creating ripples in the business, as numerous companies are rushing to get theirs to market first.
Musk’s Neuralink recently did a product demonstration that displayed its device in a monkey’s brain, allowing it to control a keyboard on a screen and type out whole words.
In July, Synchron started testing its brain implant on people. The device enables the wearer to operate a computer solely with their thoughts.
Six severely paralyzed patients from New York and Pittsburgh will have the company’s Stentrode brain implant, which is approximately the size of a paperclip.
With the use of Stentrode, patients will be able to text, email, and shop online as well as operate digital devices with just their thoughts.
Brain Implant Needs To Charge Like iPad
The first hospital in the world to implant a gadget that can correct Parkinson’s symptoms is thought to be Bristol’s Southmead Hospital.
But the Inner Cosmos Digital Pill, whose implant is roughly the size of a penny, is the tiniest and least intrusive technology available today.
The company also compares charging an Apple Watch with using the external pod. The implant operation is performed in an outpatient setting and lasts 30 minutes.
Entrepreneur Meron Gribetz, who was diagnosed with attention deficit disorder as a child, established Inner Cosmos.
The smartphone app that powers the Inner Cosmos digital pill also shows sadness and mood graphs that can be shared with a doctor.
In the first patient to undergo the treatment as part of a medical trial, a brain implant aids in the reversal of Parkinson’s symptoms.
A 36-year-old California man who was paralyzed from the neck down at age 20 is now able to speak again thanks to a brain implant that reads thoughts.
Synchron, a competitor of Elon Musk’s Neuralink, has started testing its brain implant, which enables wearers to operate computers solely with their thoughts.